"Designing Growth Strategies is in our DNA"
The orthopedic splints market size was valued at USD 2.46 billion in 2025. The market is projected to grow from USD 2.60 billion in 2026 to USD 3.95 billion by 2034, exhibiting a CAGR of 5.4% during the forecast period.
Orthopedic splints are external immobilization devices used to support, stabilize, and protect injured bones, ligaments, joints, and soft tissues during emergency care, post-operative recovery, and rehabilitation. The market growth is supported by the rising burden of musculoskeletal conditions, trauma cases, sports injuries, and geriatric falls, which is expected to drive the adoption of orthopedic splints.
Furthermore, Solventum, Essity, and Enovis held the highest market share in 2025 due to strong brand reputations, significant reach, and diversified portfolios.
Shift Toward Lightweight Synthetic Materials is Emerging as a Key Trend
Currently, there has been a shift toward synthetic, fiberglass, thermoplastic, and 3D-printed splinting materials that reduce weight, improve drying time, and enhance patient experience. Among all, fiberglass is widely used due to its high strength, faster setting, and better water resistance than plaster in many clinical scenarios. For instance, as of May 2026, 3M’s Scotchcast splint portfolio includes layered fiberglass products for rigid support and immobilization, while Essity’s Delta-Cast portfolio covers synthetic splinting and alternative splinting systems.
Download Free sample to learn more about this report.
Rising Fracture, Sports Injury, and Trauma Burden to Fuel Market Expansion
In recent years, there has been a growing incidence of musculoskeletal trauma requiring rapid, cost-effective immobilization. As a result, in emergency departments, splints are preferred for the frequent management of fractures, sprains, and soft-tissue injuries, as they are easy to apply, allow swelling, and can be adjusted during the acute phase.
In response, several key players are expanding their portfolios to meet the rising demand for higher product availability worldwide. This is expected to drive the global orthopedic splints market growth.
Skin Complications, Poor Fit, and Material Limitations to Restrict Market Growth
Although demand for orthopedic splints has been increasing, several complications have been associated with conventional splints, including pressure sores, discomfort, heaviness, heat buildup, skin maceration, and improper immobilization due to poor fit or application errors.
This is creating hesitation among physicians and patients, which is expected to limit the adoption of splints in certain conditions. Such a scenario is expected to hinder market growth over the forecast period.
Waterproof, 3D-printed, and Patient-Specific Splints Can Expand Product Adoption
In recent years, demand for customized, lightweight, waterproof, and digitally designed splints has increased, as it improves hygiene, comfort, compliance, and clinical workflow. Moreover, traditional cast and splint immobilization has seen limited innovation for decades, creating room for alternatives that are breathable, washable, and personalized. As a result, key players are entering into strategic partnerships and collaborations, which are expected to support market expansion in the coming years.
Pricing Pressure, Training Needs, and Uneven Access Challenge Market Expansion
Balancing advanced splint performance with affordability, clinician training, reimbursement, and availability across care settings has been a major challenge for their expansion. Customized waterproof or 3D-printed solutions require scanners, software, printers, trained staff, and workflow integration, which is expected to restrict adoption in smaller hospitals, public facilities, and emerging markets. Furthermore, competitive pressure from braces, casts, walking boots, and soft supports is anticipated to challenge market expansion during the forecast period.
Broad Use of Static Splints in Fracture and Sprains to Boost Segment Growth
Based on product type, the market is segmented into static splints, dynamic splints, and traction splints.
To know how our report can help streamline your business, Speak to Analyst
The static splints segment accounted for the largest orthopedic splints market share in 2025. The segment’s growth is attributed to its broad use in fracture stabilization, sprain management, tendon protection, and post-operative immobilization. They are commonly used in emergency departments and orthopedic clinics as they are simple, cost-effective, easy to apply, and suitable for acute injuries that require movement restriction. This is expected to drive their adoption over the forecast period.
Additionally, the dynamic splints segment is projected to grow at a CAGR of 7.8% during the forecast period.
High Strength, Durability and Faster Setting Time of Fiberglass Splints Drives Segment’s Dominance
By material type, the market is segmented into fiberglass splints, thermoplastic splints, metal splints, and others.
The fiberglass splints segment accounted for the largest market share in 2025. The segment’s growth is attributed to its higher preference owing to strength, lightweight profile, faster setting time, durability, and better moisture resistance compared to traditional plaster. These features are expected to support their use in high-volume emergency and orthopedic settings where clinicians need rapid immobilization and patient comfort. Moreover, the segment is estimated to hold a 36.3% share in 2026.
Additionally, the thermoplastic splints segment is anticipated to grow at a 7.3% CAGR over the forecast period.
Increasing Incidence of Lower Extremities Fractures to Boost the Segment’s Growth
By application, the market is classified into lower extremity, upper extremity, and spinal, neck & other orthopedic splints. The lower extremity is further sub-segmented into hip, knee, and ankle & foot. On the other hand, the upper extremity is sub-classified into elbow, shoulder, and hand & wrist.
The lower extremity segment accounted for the largest market share in 2025. The growth is attributed to the increasing incidence of ankle sprains, tibia/fibula injuries, knee trauma, foot fractures, and fall-related injuries. As a result, companies are expanding their line of lower-extremity orthopedic splints to meet rising demand. Moreover, the segment is projected to hold a 50.1% share in 2026.
Additionally, the upper extremity segment is expected to grow at a 5.7% CAGR during the forecast period.
Key Capabilities of Contract Manufacturers to Increase OEMs’ Outsourcing Augments Hospital Pharmacies Segment’s Growth
On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies & drug stores, and online pharmacies.
In 2025, hospital pharmacies dominated the market. Splints are frequently used immediately after emergency diagnosis, trauma evaluation, or post-operative treatment, which necessitate higher availability of such products in hospital pharmacies to support urgent immobilization and standardized orthopedic protocols. Moreover, hospital pharmacies benefit from direct physician recommendations and repeat demand from fracture and sports-injury cases. Furthermore, the segment is set to hold 43.4% share in 2026.
In addition, the retail pharmacies & drug stores segment is projected to grow at a 5.1% CAGR during the forecast period.
Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America Orthopedic Splints Market Size, 2025 (USD Billion)
To get more information on the regional analysis of this market, Download Free sample
North America accounted for the largest share of revenues in 2024, valued at USD 0.72 billion, and is projected to grow to USD 0.76 billion by 2025. The growth is attributed to high healthcare spending, strong emergency care infrastructure, frequent sports injuries, and a large elderly population vulnerable to fractures and falls.
In 2026, the U.S. is anticipated to reach USD 0.72 billion, accounting for approximately 27.9% of the global market.
Europe is projected to record a 4.5% CAGR during the forecast period, the second-highest globally, reaching USD 0.66 billion by 2026. Countries such as the U.K., Germany, France, Italy, and Spain are key contributors due to strong hospital-based fracture management practices and availability of advanced casting and splinting products, which are anticipated to drive the segment’s growth.
The U.K. market is projected to reach USD 0.11 billion by 2026, representing approximately 4.4% of global revenues.
Germany market is expected to reach around USD 0.14 billion by 2026, accounting for approximately 5.3% of global revenue.
By 2026, the Asia Pacific market is projected to reach approximately USD 0.65 billion, making it the third-largest market worldwide. The region’s growth is driven by a large patient pool of trauma cases resulting from road accidents, and by expanding healthcare network, which is contributing to higher adoption of splints in countries such as India, China, Australia, South Korea, and Southeast Asia.
Japan is projected to generate approximately USD 0.12 billion in revenue by 2026, representing nearly 4.6% of the global market.
China’s is anticipated to reach around USD 0.26 billion by 2026, accounting for nearly 10.0%of global revenues.
India’s market is expected to reach approximately USD 0.09 billion by 2026, accounting for around 3.5% of global market revenue.
Both Latin America and the Middle East & Africa are anticipated to witness moderate growth, with the Latin America market estimated to reach approximately USD 0.27 billion by 2026. The growth is attributed to increasing sports medicine investments, the rising burden of road accidents, and the development of private hospitals and specialty clinics are expected to increase the utilization of orthopedic splints in the region.
By 2026, the GCC market is estimated to reach approximately USD 0.10 billion, representing around 3.8% of global revenues.
Focus on Product Quality, Material Innovation, and Hospital Relationships by Key Players to Strengthen Market Competition
The orthopedic splints market is moderately fragmented, with major players competing through various growth initiatives, including material innovation, distribution reach, and hospital relationships. In 2025, Solventum, Essity, and Enovis held the majority of the market share. This share is due to a focus on fiberglass and synthetic splinting, given established fracture-management portfolios. Moreover, other major players such as Thuasne, Breg, Inc., are focusing on acquisitions, product launches, and digital customization to strengthen their market presence worldwide.
The report provides an in-depth assessment of all market segments, highlighting the key growth drivers, emerging trends, opportunities, major restraints, and challenges shaping the market. It further covers technological advancements, the incidence of major orthopedic conditions, recent industry developments, company market share analysis, and profiles of leading market players.
Request for Customization to gain extensive market insights.
| ATTRIBUTE | DETAILS |
| Study Period | 2021-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2021-2024 |
| Growth Rate | CAGR of 5.4% from 2026-2034 |
| Unit | Value (USD Billion) |
| Segmentation | By Product Type, Material Type, Application, Distribution Channel,, and Region |
| By Product Type |
|
| By Material Type |
|
| By Application |
|
| By Distribution Channel |
|
| By Region |
|
Fortune Business Insights says that the global market value stood at USD 2.46 billion in 2025 and is projected to reach USD 3.95 billion by 2034.
In 2025, the North America market value stood at USD 0.76 billion.
The market is expected to exhibit a CAGR of 5.4% during the forecast period of 2026-2034.
The static splints segment led the market by product type.
The key factor driving the market is the rising burden of fractures, sports injuries, and trauma.
Solventum, Essity, and Enovis are the top players in the market.
North America held the largest share of the market.
Get 30-60 hrs Free Customization
Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.
Related Reports
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )